Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

2

About Daniel Vasella

Daniel Vasella Headquarter Location

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Daniel Vasella News

Daniel Vasella named as new chairman of Numab

Sep 30, 2020

Dr Daniel Vasella, former chairman and chief executive of Swiss pharma giant Novartis, has been appointed… To continue reading The Pharma Letter please login ,   subscribe  or  claim a 7 day free trial subscription  and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. Or, if you're only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing, CRO and CMO, and regulation), then you can take our £10 per month channel subscription offer, which gives you access to all our news articles and in-depth content on this subject.

Daniel Vasella Investments

2 Investments

Daniel Vasella has made 2 investments. Their latest investment was in mPharma as part of their Series C on April 4, 2020.

CBI Logo

Daniel Vasella Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/10/2020

Series C

mPharma

$17M

Yes

3

3/9/2020

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/10/2020

3/9/2020

Round

Series C

Series B - II

Company

mPharma

Subscribe to see more

Amount

$17M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

3

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.